Skip to content

Children's Health in London and Luton (CHILL)

Investigating the Impact of London's Ultra Low Emission Zone on Children's Respiratory Health

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04695093
Acronym
CHILL
Enrollment
3312
Registered
2021-01-05
Start date
2018-06-05
Completion date
2023-07-01
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Development, Pollution; Exposure, Respiratory Disease

Keywords

respiratory disease

Brief summary

Investigating the impact of London's Ultra Low Emission Zone on children's respiratory health

Detailed description

Strong evidence links urban air pollution to restrictions in children's lung growth and development and other adverse effects, including increases in respiratory and allergy symptoms, respiratory infections, asthma, and health care use. Effective interventions are urgently needed that reduce air pollution and improve child health. Low Emission Zones (LEZ) are becoming widespread but are expensive to implement and of unproven health benefit. London has some of the worst air pollution in Europe. London's Ultra Low Emission Zone (ULEZ) is the central component of London's air quality strategy. Its implementation provides a unique opportunity to test the impact of a city-wide LEZ on children's health. The intervention: The ULEZ is an area within which all vehicles must meet exhaust emission standards or pay a daily charge to travel. It will be implemented and paid for by Transport for London. Starting in 2019, the ULEZ will initially cover London's central Congestion Charging Zone, an area bounded by the London Inner Ring Road, that includes the City of London plus adjacent areas of eight radially adjoining Boroughs. It is projected to deliver for central London by 2020 emission reductions of -49% for NOx; - 47% for NO2; and -11% for PM10. Subject to consultation, the ULEZ will subsequently extend to include an inner London area (within London's North and South Circular roads), and a London-wide area, for heavy vehicles only. Questions: 1. What is the impact of the ULEZ on children's lung growth (the primary outcome)? 2. What is the impact of the ULEZ on secondary outcomes, including self-reported symptoms, respiratory infection, health care use and costs? 3. Does the ULEZ reduce health inequalities? 4) Is the ULEZ good value for money? Study design: Quasi-experimental study using a parallel cohort design. Population: 1520 children aged 6-9 yrs old, recruited in 26 London primary schools (school years 2, 3 and 4) in London's Central Ultra Low Emission Zone. Intervention: Ultra Low Emission Zone Comparison: 1520 children aged 6-9 yrs old, recruited in 26 primary schools (school years 2, 3 and 4) in Luton, matched for ethnicity, deprivation and baseline air quality. Outcome: PRIMARY: Lung function growth (post-bronchodilator forced expiratory volume in one second (FEV1) measured by high quality spirometry at sequential annual school visits over four years. SECONDARY: Forced vital capacity (FVC), exhaled nitric oxide (FeNO), quality of life, respiratory infections, health care use, health costs. Sample size: To detect a 15ml/year FEV1 difference between central and outer London cohorts at 90% power and 0.05 significance requires children in each cohort, inflated to allow for clustering effect of schools, spirometry success, child and school attrition, and pre-specified sub group analyses, giving a total of 3120 children (60 children from 26 schools in each cohort). Duration: 6 years Air quality data: Modeled exposures by London Air Quality Network Data management: NIHR accredited Pragmatic Clinical Trials Unit Analysis: Interaction analysis controlling for effect modifiers (eg passive smoke; ethnicity); health economic cost consequence analysis.

Interventions

OTHERUltra Low Emission Zone (ULEZ)

The ULEZ comprises a Central London zone, implemented on 8th April 2019, within which polluting vehicles are subject to a charge. Using number plate recognition technology, a daily penalty charge notice is issued for vehicles entering this central zone not meeting the standard of Euro 4 for petrol, Euro 6/VI for diesel, and Euro for motorcycles. The ULEZ will subsequently be extended to include: 1. In 2020, a London-wide ULEZ for heavy duty vehicles (HDV) within the LEZ boundary (green zone). HDVs not meeting Euro 6 standard will be charged daily. 2. In 2021, an Inner London ULEZ area for all light duty vehicles (LDV) within the boundary of the North and South Circular Roads (yellow zone). Vehicles not meeting the above criteria will be charged daily as for the Central London area.

Sponsors

Queen Mary University of London
Lead SponsorOTHER
King's College London
CollaboratorOTHER
University of Edinburgh
CollaboratorOTHER
University of Bedfordshire
CollaboratorOTHER
University of Cambridge
CollaboratorOTHER
University of Southern California
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
9 Years to 9 Years
Healthy volunteers
Yes

Inclusion criteria

* Inclusion criteria for schools: * Primary schools within, or with catchment areas that include, the Central London ULEZ. * Primary schools within the Borough of Luton and town of Dunstable. * State or independent sectors. Inclusion criteria for children: • Children attending a study school, in years 2, 3, or 4, at study inception.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Lung function growth as change in forced expiratory volume in one second (FEV1) per yearFour years, 2018 -2021Measured by annual spirometry, as annual change in FEV1/year over 4 years

Secondary

MeasureTime frameDescription
Air quality, nitrogen dioxide (NO2) concentration derived from the the KCLUrban dispersion modelFour years, 2018 -2021Annual nitrogen dioxide (NO2) concentration (micrograms/cubic meter NO2)
Air quality, oxides of nitrogen (NOx) concentration derived from the KCLUrban dispersion modelFour years, 2018 -2021Annual oxides of nitrogen (NOx) concentration (micrograms/cubic meter NOx)
Air quality, particulate matter diameter <2.5microns derived from the KCLUrban dispersion modelFour years, 2018 -2021Annual particulate matter diameter \<2.5microns (PM2.5) concentration (micrograms/cubic meter PM2.5)
Lung capacity as FVC (forced vital capacity)Four years, 2018 -2021Measured by annual spirometry, as FVC in litres
Annual prevalence of wheeze, as proportion (%) of respondents reporting wheezeFour years, 2018 -2021International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire for 6-7 year olds
Annual prevalence of eczema, as proportion (%) of respondents reporting eczemaFour years, 2018 -2021International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire for 6-7 year olds
Annual prevalence of rhinitis, as proportion (%) of respondents reporting rhinitisFour years, 2018 -2021International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire for 6-7 year olds
Annual prevalence/participant of upper respiratory tract infectionsFour years, 2018 -2021Electronic download of coded NHS health record data
Annual prevalence/participant of lower respiratory tract infectionsFour years, 2018 -2021Electronic download of coded NHS health record data
Physical activity, as Percentage time in Moderate to Vigorous Physical activity per participant (MVPA)Four years, 2018 -2021Annual hip accelerometer records of participants, measured over one week
Annual health care use per participantFour years, 2018 -2021Electronic download of coded NHS health record data
Annual health care costs per participantFour years, 2018 -2021Electronic download of coded NHS health record data and self report data
Cognitive function as average Movement Time in seconds (MT) on the Clinical Kinematic Assessment TestThree years, 2019 -2021Annual Clinical Kinematic Assessment Test
Child Quality of Life as score out of 40Four years, 2018 -2021Annual parental completion of the CHU9D (Child Health Utility 9 Dimension) questionnaire

Countries

United Kingdom

Contacts

STUDY_DIRECTORMays Jawad, PhD

Queen Mary University of London

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026